Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Surgery Partners, Inc.

SGRY · Nasdaq · CIK 0001638833 · Healthcare · Medical Care Facilities

INSIDER SIGNAL

53.1 / 100

1 buyers · 2 purchase transaction lines · $304.7K gross purchase

WHY THIS SIGNAL?

Buyer breadthLow
Purchase sizeModerate
RoleStrong
RecencyLow
ConvictionStrong
Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+7.0 / 35
Purchase size+12.5 / 25
Role+20.0 / 20
Recency+3.6 / 10
Conviction+10.0 / 10

What is holding the score back?

  • ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
  • ⚠ Purchase activity is becoming less recent
  • ✓ Role scores high · most senior buyer: Director

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
DeLuca TeresaDirector
○●●
HENDRIX BLAIR EDirector,TenPercentOwner
○○
Deane John ADirector
○
Forese Laura LDirector
○
ADLERZ CLIFFORD GDirector
○
Dean Lloyd HDirector
○
● Purchase▼ Sale○ Other

Showing the six most active owners; 1 additional owner(s) remain in Form 4 evidence.

Purchase breadth & concentration

QUALIFYING BUYERS1
PURCHASE CONCENTRATION100%Largest buyer: DeLuca Teresa · $304.7K
CLUSTER BUYING · 15D1 insiderPeak activity: 2026-08-18–2026-08-18

Roles in the peak window: Director. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

53.1 / 100

Latest recorded score

↓ -0.2 ptsversus the previous recorded snapshot
  1. 53.6
  2. 53.5
  3. 53.4
  4. 53.3
  5. 53.1

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

2Purchases
12Sales
26Other Form 4 lines
23SEC filings · 365 days
BUYING2 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER8 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
-1.6%
3M
-13.1%
6M
+7.6%
12M
-32.5%

Volatility & liquidity

Volatility
49.2%
Beta
—
Avg daily value
USD 30.1M

Valuation

Market cap
USD 1.8B
P/E
—

Fundamentals

Profit margin
-2.4%
ROE
-4.5%
Industry
Medical Care Facilities

Market data

Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, Profit margin, ROE · Fiscal year ended: 2025-12-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-08-03 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
14,349,417
Previous report
13,288,944
Avg daily volume
2,682,773
Days to cover
5.3

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-18DeLuca TeresaPurchase (P)Common Stock11,250USD 14.33USD 161,212SEC filing ↗
2026-08-18DeLuca TeresaPurchase (P)Common Stock10,000USD 14.35USD 143,500SEC filing ↗
2022-11-21TURNER BRENTPurchase (P)Common Stock10,000USD 24.50USD 245,000SEC filing ↗
2022-11-21DeLuca TeresaPurchase (P)Common Stock20,000USD 24.50USD 490,000SEC filing ↗
2021-08-10DeLuca TeresaPurchase (P)Common Stock2,000USD 46.70USD 93,400SEC filing ↗

Form 4 evidence

40 transaction lines in the latest 365-day window; 391 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-18DeLuca TeresaPurchase (P)Common Stock11,250USD 14.33USD 161,212SEC filing ↗
2026-08-18DeLuca TeresaPurchase (P)Common Stock10,000USD 14.35USD 143,500SEC filing ↗
2026-06-18HENDRIX BLAIR EAward / grant (A)Common Stock34,364USD 14.55USD 499,996SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-18DeLuca TeresaPurchase (P)Common Stock11,250USD 14.33USD 161,212SEC filing ↗
2026-08-18DeLuca TeresaPurchase (P)Common Stock10,000USD 14.35USD 143,500SEC filing ↗
2026-06-18HENDRIX BLAIR EAward / grant (A)Common Stock34,364USD 14.55USD 499,996SEC filing ↗
2026-06-05TURNER BRENTAward / grant (A)Common Stock11,670USD 13.71USD 159,996SEC filing ↗
2026-06-05HENDRIX BLAIR EAward / grant (A)Common Stock11,670USD 13.71USD 159,996SEC filing ↗
2026-06-05Forese Laura LAward / grant (A)Common Stock11,670USD 13.71USD 159,996SEC filing ↗
2026-06-05Deane John AAward / grant (A)Common Stock11,670USD 13.71USD 159,996SEC filing ↗
2026-06-05Dean Lloyd HAward / grant (A)Common Stock11,670USD 13.71USD 159,996SEC filing ↗
2026-06-05DeLuca TeresaAward / grant (A)Common Stock11,670USD 13.71USD 159,996SEC filing ↗
2026-06-05ADLERZ CLIFFORD GAward / grant (A)Common Stock11,670USD 13.71USD 159,996SEC filing ↗
2026-03-16Evans Jason EricSale (S)Common Stock20,400USD 12.47USD 254,388SEC filing ↗
2026-03-16Doherty David TSale (S)Common Stock8,867USD 12.50USD 110,838SEC filing ↗
2026-03-13Burkhalter DanielleSale (S)Common Stock3,469USD 12.83USD 44,507SEC filing ↗
2026-03-13Brittenham MarissaSale (S)Common Stock3,657USD 12.54USD 45,859SEC filing ↗
2026-03-12Baldock JenniferSale (S)Common Stock5,798USD 13.17USD 76,360SEC filing ↗
2026-03-06Webb William TrentonSale (S)Common Stock272USD 13.93USD 3,789SEC filing ↗
2026-03-06Evans Jason EricSale (S)Common Stock11,462USD 13.79USD 158,061SEC filing ↗
2026-03-06Doherty David TSale (S)Common Stock14,574USD 13.84USD 201,704SEC filing ↗
2026-03-06Burkhalter DanielleSale (S)Common Stock7,736USD 13.60USD 105,210SEC filing ↗
2026-03-06Brittenham MarissaSale (S)Common Stock8,785USD 13.70USD 120,354SEC filing ↗
2026-03-06Baldock JenniferSale (S)Common Stock10,082USD 13.70USD 138,123SEC filing ↗
2026-03-05Webb William TrentonSale (S)Common Stock1,794USD 13.86USD 24,865SEC filing ↗
2026-03-05Webb William TrentonAward / grant (A)Common Stock31,892USD 14.11USD 449,996SEC filing ↗
2026-03-05Oppenheimer Justin RobertAward / grant (A)Common Stock42,523USD 14.11USD 600,000SEC filing ↗
2026-03-05Evans Jason EricAward / grant (A)Common Stock278,106USD 14.11USD 3,924,076SEC filing ↗
2026-03-05Doherty David TAward / grant (A)Common Stock141,743USD 14.11USD 1,999,994SEC filing ↗
2026-03-05Burkhalter DanielleAward / grant (A)Common Stock43,230USD 14.11USD 609,975SEC filing ↗
2026-03-05Brittenham MarissaAward / grant (A)Common Stock43,230USD 14.11USD 609,975SEC filing ↗
2026-03-05Baldock JenniferAward / grant (A)Common Stock106,307USD 14.11USD 1,499,992SEC filing ↗
2026-01-13Oppenheimer Justin RobertAward / grant (A)Common Stock77,736USD 16.08USD 1,249,995SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerSGRY
CIK0001638833
SectorHealthcare
IndustryMedical Care Facilities Yahoo Finance
SEC SIC8062 Services-General Medical & Surgical Hospitals, NEC
ExchangeNasdaq

Data coverage

Local Form 4 history391 transaction lines from 2020-01-04 to 2026-08-18
5 P purchase lines · 172 S sale lines · 214 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.